Detalles de la búsqueda
1.
Selection of long COVID symptoms influences prevalence estimates in a prospective cohort
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22282120
2.
Evolution of COVID-19 symptoms during the first 9 months after illness onset
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256710
3.
IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-481778
4.
SARS-CoV-2 Infection and Transmission Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-255810
5.
Mapping the antigenic diversification of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268582
6.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256092
7.
Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257797
8.
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-512216
9.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257441
10.
A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-470767
11.
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-365726
Resultados
1 -
11
de 11
1
Próxima >
>>